TG Therapeutics, Inc. (TGTX)

NasdaqCM • Currently down 1.54 (-2.37%) in today's trading session

Track congressional stock trades in TG Therapeutics, Inc. (TGTX). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

TG Therapeutics, Inc. is currently trading at $63.34, positioned at 89% of its 52-week range ($26.76 – $68.03).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$63.34
24h Change
-1.54 (-2.37%)
52 Week Range
$26.76–$68.03
View on NASDAQ

TG Therapeutics, Inc. Price History and Technical Analysis

Congressional Trading Activity for TGTX

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$9.57B

Volume

2.09M

Beta

1.81

P/E Ratio

22.95

Fundamentals

EPS

$2.76

Div. Yield

-

Open

$64.32

Day Range

$63.12 – $65.64

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Michael S. Weiss
IPO Date
2010-05-03

Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solution...

Earnings

Next Report

Q4 2026

25 Feb

EPS Est.

$0.52

Rev. Est.

$290.2M

Days Until

95

Recent Quarters

Q3 20269 Nov
EPS$0.35
Miss 2.6%
Q3 20262 Nov
EPS-
Q2 20263 Aug
EPS$0.05
Miss 83.6%
Q1 20266 May
EPS$0.14
Miss 39.1%
Q4 202526 Feb
EPS$0.14
Miss 60.0%
Q3 20253 Nov
EPS$2.43
Beat 912.5%
Q2 20254 Aug
EPS$0.17
Miss 46.9%
Q1 20255 May
EPS$0.03
Miss 83.3%
Q4 20243 Mar
EPS$0.15
Beat 87.5%
Q3 20244 Nov
EPS$0.02
Miss 33.3%
Q2 20246 Aug
EPS$0.04
Beat 180.0%
Q1 20241 May
EPS$-0.07
Miss 96.0%
Q4 202328 Feb
EPS$-0.09
Beat 25.0%
Q3 20231 Nov
EPS$0.73
Beat 508.3%
Q2 20231 Aug
EPS$-0.34
Miss 30.8%
Q1 20231 May
EPS$-0.28
Beat 22.2%
Q4 202228 Feb
EPS$-0.39
Miss 50.0%
Q3 202210 Nov
EPS$-0.26
Beat 21.2%
Q2 20228 Aug
EPS$-0.30
Beat 38.8%
Q1 202210 May
EPS$-0.51
Beat 7.3%
Q4 20211 Mar
EPS$-0.70
Miss 12.9%
Q3 20214 Nov
EPS$-0.65
Miss 16.1%
Q2 20212 Aug
EPS$-0.59
Miss 22.9%
Q1 202110 May
EPS$-0.69
Miss 32.7%
Q4 20202 Mar
EPS$-0.71
Miss 24.6%
Q3 20209 Nov
EPS$-0.73
Miss 78.0%
Q2 202010 Aug
EPS$-0.47
Miss 46.9%
Q1 202011 May
EPS$-0.48
Miss 29.7%
Q4 20193 Mar
EPS$-0.38
Beat 15.6%
Q3 201912 Nov
EPS$-0.67
Miss 86.1%
Q2 20199 Aug
EPS$-0.42
Beat 2.3%
Q1 201910 May
EPS$-0.43
Beat 8.5%
Q4 20181 Mar
EPS$-0.69
Miss 56.8%
Q3 20189 Nov
EPS$-0.43
Beat 21.8%
Q2 20187 Aug
EPS$-0.59
Miss 7.3%
Q1 20188 May
EPS$-0.59
Miss 28.3%
Q4 20178 Mar
EPS$-0.46
Beat 0.0%
Q3 20178 Nov
EPS$-0.48
Miss 4.3%
Q2 20179 Aug
EPS$-0.45
Beat 2.2%
Q1 20175 May
EPS$-0.52
Miss 23.8%
Q4 201610 Mar
EPS$-0.48
Miss 23.1%
Q3 20167 Nov
EPS$-0.50
Miss 61.3%
Q2 20168 Aug
EPS$-0.33
Miss 13.8%
Q1 201610 May
EPS$-0.28
Beat 20.0%
Q4 20157 Mar
EPS$-0.37
Miss 12.1%
Q3 20159 Nov
EPS$-0.28
Beat 22.2%
Q2 201510 Aug
EPS$-0.38
Miss 18.8%
Q1 20154 May
EPS$-0.39
Miss 8.3%
Q4 201411 Mar
EPS$-0.35
Miss 16.7%
Q3 201410 Nov
EPS$-0.51
Miss 45.7%
Q2 201421 Jul
EPS$-0.36
Miss 28.6%
Q1 201412 May
EPS$-0.07
Beat 66.7%
Q4 20135 Mar
EPS$-0.16
Beat 15.8%
Q3 201311 Nov
EPS$-0.16
Beat 36.0%
Q2 20131 Aug
EPS$-0.29
Miss 61.1%
Q1 201313 May
EPS$-0.17
Miss 21.4%
Q4 201221 Mar
EPS$-0.04
Beat 73.3%
Q3 20128 Nov
EPS$-0.16
Q2 20129 Aug
EPS$-0.16
Q1 201214 May
EPS$-2.03
Miss 3283.3%
Q4 201114 Mar
EPS$-0.23
Q3 201114 Nov
EPS$-0.21
Q2 201115 Aug
EPS$-1.64
Q1 201116 May
EPS$83.04
Q4 201031 Mar
EPS$0.01
Q3 201015 Nov
EPS$0.96
Q2 201016 Aug
EPS$43.21
Q1 201024 May
EPS$-54.27
Q4 200931 Mar
EPS$-0.01
Q3 200916 Nov
EPS$-16.57
Q2 200914 Aug
EPS$-55.45
Q1 200915 May
EPS$-30.34
Q4 200831 Mar
EPS$0.01
Q3 200819 Nov
EPS$-55.53
Q2 200819 Aug
EPS$-56.64
Q1 200820 May
EPS$-62.10
Q4 200731 Mar
EPS$-0.08
Q3 200714 Nov
EPS$-112.50
Miss 300.1%
Q2 200714 Aug
EPS$-196.87
Miss 250.0%
Q2 20079 Jul
EPS$-112.50
Miss 33.3%
Q1 20072 Apr
EPS$-0.15
Q3 200614 Nov
EPS$-84.37
Beat 0.0%
Q2 200614 Aug
EPS$-112.50
Beat 0.0%
Q1 200615 May
EPS$-140.62
Beat 0.0%
Q3 200514 Nov
EPS$-114.13
Q2 200515 Aug
EPS$-925.67
Q1 200516 May
EPS$-139.92
Q4 200431 Mar
EPS$-171.21
Q3 200415 Nov
EPS$-229.70
Q2 200416 Aug
EPS$-90.61
Q1 200414 May
EPS$-117.83
Q4 200330 Mar
EPS$-162.39
Q3 200314 Nov
EPS$-391.65
Q2 200315 Aug
EPS$-93.46
Q1 200315 May
EPS$-91.69
Q1 200311 Apr
EPS$-80.55
Q3 20027 Nov
EPS$-485.44
Q2 200214 Aug
EPS$7.58
Q1 200215 May
EPS$-519.63
Q1 20021 Apr
EPS$-470.57
Q3 200119 Nov
EPS$-1436.64
Q2 200120 Aug
EPS$-4183.69
Q1 20014 May
EPS$3675.17
Q1 200117 Apr
EPS$-794.01
Q3 200020 Nov
EPS$-2245.79
Q2 200021 Aug
EPS$-7281.50
Q1 200011 May
EPS$-3655.81
Q4 199930 Mar
EPS$-1591.51
Q3 199915 Nov
EPS$-882.35
Q2 199911 Aug
EPS$-1775.15
Q1 19993 May
EPS$-2727.27
Q4 199825 Mar
EPS$-3939.39
Q3 19985 Nov
EPS$-3773.58
Q2 199829 Jul
EPS$3584.23
Q1 199812 May
EPS$-5306.12
Q4 199723 Mar
EPS$-6122.45
Q3 199713 Nov
EPS$-4651.16
Q2 199715 Aug
EPS$-8372.09
Q1 199715 May
EPS$-4347.83
Q4 199631 Mar
EPS$-4830.92
Q3 19967 Nov
EPS$-5314.01
Q2 19968 Aug
EPS$-4232.80
Q4 199531 Mar
EPS$-4232.80

No dividend data available for this stock.

Stock Splits

Split History

30 Apr 2012Reverse Split
Ratio4:225
14 Jul 2011Reverse Split
Ratio1:50
29 Sept 2003Reverse Split
Ratio1:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.